IDO has been investigated in cervical, colorectal, hepatocellular, ovarian carcinoma, endometrial cancer and thyroid cancer [14-18], but to our knowledge, no detailed studies have investigated the expression of IDO in NPC. The gene discussed is IDO1; the disease is nasopharyngeal carcinoma.